Company Overview and News

 
Trading ideas: Gabungan AQRS, Country Heights, JAKS, Bioalpha, PUC

7h thestar.com.my
KUALA LUMPUR: Gabungan AQRS Bhd , Country Heights Holdings Bhd , JAKS Resources Bhd , Bioalpha Holdings Bhd and PUC Bhd are among the stocks to watch on Friday, according to JF Apex Research.
5226 0179 5738 4723

 
Country Heights to pump RM500mil into Mines Car

7h thestar.com.my
CHHB executive director Matahari Lee (pic) said the company will be consolidating RM1.3bil worth of assets and facilities with the Klang Valley for MCCC.
5738

 
KLCI seen trading range bound, hurdle at 1,740

8h theedgemarkets
KUALA LUMPUR (Oct 19): The FBM KLCI is seen trading range bound,with immediate hurdle at 1,740 points today following the overnight fall at most global markets as well as the unveiling of the 11th Malaysia Plan mid-term review.
5226 0179 5738 4723

 
Gabungan AQRS, PUC, Country Heights, Maxis, JAKS and Bioalpha

16h theedgemarkets
KUALA LUMPUR (Oct 18): Based on corporate announcements and news flow today, stocks in focus on Thursday (Oct 18) may include Gabungan AQRS Bhd, PUC Bhd, Country Heights Holdings Bhd, Maxis Bhd, JAKS Resources Bhd and Bioalpha Holdings Bhd.
5226 0179 5738 4723 BSMAF 1818

 
Short Position

2018-10-06 thestar.com.my
GUESS what’s happening in the media industry – Singapore Press Holdings Ltd (SPH) is said to be joining forces with Keppel Corp to take over M1 Ltd, the smallest of wireless operators in the island state.
SGPRY 5738 6888 CCV.CL CCV CMCSA SGPRF CCZ AXXTF CMCSK

 
Country Heights to take ‘patient, prudent steps’ for ICO

2018-10-04 theedgemarkets
KUALA LUMPUR: Country Heights Holdings Bhd (CHHB) has assured shareholders it will be taking “very patient and prudent steps” in its plan to conduct an initial coin offering (ICO), amid the Securities Commission Malaysia’s (SC) strict stance on the controversial method of fundraising.
5738 BSMAF 1818

 
Country Heights to hold EGM on ICO proposal

2018-10-04 thestar.com.my
In a Bursa Malaysia filing, CHHB acknowledged that being the first public-listed company to head towards this new field, an EGM would help to clear the confusion among many who may not comprehend blockchain technology and the many cryptocurrencies in the world today.
5738 BSMAF 1818

 
KLCI seen trending sideways, hover below 1,805-level

2018-10-03 theedgemarkets
KUALA LUMPUR (Oct 4): The FBM KLCI is expected to trend sideways today, in line with the slight gains at most regional markets and hover below the 1,805 level.
4863 5738 6888 7168 AXXTF MYTEF

 
Axiata, Maxis, TM, TIME, APFT, Country Heights and PRG

2018-10-03 theedgemarkets
KUALA LUMPUR (Oct 3): Based on corporate announcements and news flow today, companies in focus on Thursday (Oct 4) may include: Axiata Group Bhd, Maxis Bhd, Telekom Malaysia Bhd, TIME dotcom Bhd, APFT Bhd, Country Heights Holdings Bhd and PRG Holdings Bhd.
4863 5738 6888 7168 AXXTF MYTEF

 
Country Heights pledges to be 'very patient and prudent' in issuing its own cryptocurrency

2018-10-03 theedgemarkets
KUALA LUMPUR (Oct 3): Country Heights Holdings Bhd (CHHB), which announced on Sept 21 a plan to issue its own cryptocurrency called 'Horse Currency' that is backed by the group's existing assets, has assured shareholders it will be taking "very patient and prudent steps" in the matter.
5738 BSMAF 1818

 
Home prices can come down if certain issues addressed, say developers

2018-10-02 theedgemarkets
SERI KEMBANGAN (Oct 2): While the government is asking property developers to lower home prices following the Sales and Service Tax (SST) exemption on construction services and building materials, industry players said lower prices can be achieved if issues such as labour shortage and the lofty compliance and development costs are addressed.
5738

 
KLCI to consolidate, immediate support at 1,800 points

2018-09-23 theedgemarkets
KUALA LUMPUR (Sept 24): The FBM KLCI is expected to consolidate today with immediate support at 1,800 points.
5754 4863 5738 6459 UPBMF 5066 MYPRY MYTEF 5014 2089 9334

 
Country Heights plans asset-backed cryptocurrency

2018-09-22 thestar.com.my
PETALING JAYA: Loss-making property developer Country Heights Holdings Bhd plans to issue an asset-backed cryptocurrency, which will used mainly as an utility or reward token with the company’s services or product offerings.
5738 BSMAF 1818

 
MAHB, United Plantations, Utusan, TM, Binasat, KESM, NTPM, Country Heights and MNRB

2018-09-21 theedgemarkets
KUALA LUMPUR (Sep 21): Based on corporate announcements and news flow today, stocks in focus for Monday (Sep 24) may include the following: Malaysia Airports Holdings Bhd, United Plantations Bhd, Utusan Melayu (Malaysia) Bhd, Telekom Malaysia Bhd, Binasat Communications Bhd, KESM Industries Bhd, NTPM Holdings Bhd, Country Heights Holdings Bhd and MNRB Holdings Bhd.
UPBMF 5066 5088 2089 5014 9334 5754 4863 5738 6459 MYPRY MYTEF 1902

 
Founder Lee Kim Yew wants Country Heights to issue its own cryptocurrency

2018-09-21 thestar.com.my
KUALA LUMPUR: Tan Sri Lee Kim Yew, the founder and chairman of Country Heights Holdings Bhd , wants the company to mint its own cryptocurrency.
5738

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...